GBA's "2021 Stock Phantasma"

Discussion in 'Stocks' started by stonedinvestor, Jan 1, 2021.

  1. janes

    janes

    thanks stoney, appreciate it. but...not so sure that with my temperament i can pull it off. i have found that if i'm home, i pretty much watch the numbers. my guess is that it's easier, or at least feeds my neurotic brain more vigorously than the other stuff i do. the other part of my life involves pretty slow, careful work, and this watching the numbers doesn't work well with it. i do really like the research part of investing, though. definitely going to close my webull acct and just move everything to interactive brokers. they make these robinhood/ webull apps so that they are pretty addictive. also, have sold the algae stock. that one is complicated to explain.
     
    #2141     Mar 2, 2021
  2. Elys Game comments on legislation to legalize single event Canada sport betting

    Van take a look at Elys for me. Stop staring at the announcer and take a deeper look....


    UPLAND)


    Pool Covers. Why they are important.
     
    #2142     Mar 2, 2021
  3. not so sure that with my temperament i can pull it off. i have found that if i'm home, i pretty much watch the numbers.

    This is where the constant smoking of pot and taking of gummies comes in.
     
    #2143     Mar 2, 2021
    janes likes this.
  4. Elys Game Technology (NASDAQ:ELYS) recently expanded its strategic partnership with Sportradar, a leading provider of sports betting and sports entertainment products and services worldwide, in order to offer a broad range of planned live, in-game wagering options at U.S. retail sports betting locations the company intends to open. The new agreement will give Elys access to Sportradar official pre-game and in-play data for major U.S. sports. Sportradar offers data coverage encompassing more than 60 global sports. ELYS expects this to enhance its product portfolio for live streaming sporting events and to create new opportunities in the important U.S. sports betting market. The company intends to open the first U.S. locations in Washington DC.

    The company operates in the international leisure gaming industry and is a licensed gaming operator in Italy, offering a variety of lottery, casino and sports betting options there through both an onsite physical retail channel and a digital platform via its proprietary betting software, the Elys Game Board, that is integrated with a built-in player gaming account management system and sports book. We believe recent initiatives highlight the importance of the company’s growth strategy and of the North American market to that growth strategy.

    Industry forecasts support expectation of significant market opportunity in the U.S. For example, Morningstar forecasts that U.S. sports betting can reach $6.2 billion in industry revenue by 2024. Other industry forecasts are even higher, supporting ELYS’s expectation that the U.S. sports betting and online gaming market represents a sizable opportunity for its platform.

    Financial Update

    The company also reported preliminary 4Q20 metrics showing year-over-year revenue advances and suggesting market share gains. ELYS recently reported 4Q20 preliminary net gaming revenue of about $13.1 million, up 26% compared to $10.4 million in 4Q19. Web-based gross gaming revenue advanced roughly 69% year-over-year. By comparison, year-to-date revenue through 3Q 2020 was about flat year-over-year ($24.7 million compared to $25.1 million), reflecting the economic downturn caused by the COVID-19 pandemic and the closure of many retail venues that form the basis for much of the company’s bricks-and-mortar channel.


    Benefits of Omni-Channel Strategy

    Players have shifted from bricks-and-mortar to online during the pandemic, with the above-noted roughly 69% year-over-year advance in web-based gross gaming revenue. ELYS’s turnover, or betting handle, has grown from about $122 million in 2016 to $454 million in 2019 and is expected to continue to rise as the company pursues expansion initiatives. Management believes the Elys platform is highly scalable and can continue to support its growth initiatives and expansion, reflecting the company’s entrance into new markets combined with potential M&A transactions and the anticipated growth of the e-sports sector.

    [​IMG]
    In Italy, ELYS’s 4Q20 online gaming performance advanced 65% compared to a roughly 37.5% year-over-year revenue improvement in the nation’s online sports betting sector, according to Italian news agency AGIMEG, suggesting market share gains for ELYS. The company attributes the gains to its omni-channel distribution approach, among other factors.

    The company’s earlier 2020 results also illustrate the benefits of the omni-channel strategy, we believe. For instance, some 82% of turnover was web-based in 3Q 2020 compared to 40% in the same period of 2019. Players have shifted to online access during the pandemic; ELYS expects these sources of turnover – and fee revenue – to revert to more normalized levels post-COVID-19.


    ***DISCLOSURE: Zacks SCR has received compensation from the issuer directly,
    YIKES Zacks WTF!<---
     
    #2144     Mar 2, 2021
  5. Elys Game Technology reports preliminary net gaming revenue $13.1M 01/28 ELYS Elys Game Technology reported that preliminary, unaudited net gaming revenue increased by 26% to approximately $13.1 million for fourth quarter of 2020 compared to $10.4 million for the same period in the previous year. Additionally, web-based gross gaming revenue increased by approximately 69% in Q4 2020 compared to the same period in the previous year. As reported by Italy's leading gambling, betting, and gaming news agency AGIMEG spending within the online sports betting sector in Italy reached almost $1.2bln for the full year of 2020, an increase of approximately 37.5% over 2019 according to statistics provided by the Italian regulator "ADM". Despite the highly competitive market in Italy, Elys grew by 56% gaining market share while further strengthening its competitive position in the mobile and online channel. Matteo Monteverdi, CEO of Elys, commented, "We continue to generate very strong year-over-year revenue growth in our foundational operations despite the impact of COVID-19. Moreover, our online gaming performance in Italy increased by 65% in 2020, and we believe that we have been able to navigate the current market far better than many of our peers. We credit this growth to our omni-channel distribution approach, which combines the best of both online and land-based retail betting. We believe this multi-faceted approach allows us to remain nimble as an organization and quickly adapt to evolving market conditions such as the current pandemic. "Our goal is to not only establish ourselves as one of the world's leading sports betting enterprises but, more importantly, aligning our product and service offerings to the needs of our B2B clients as well as B2C consumers in order to build a well-managed organization that is both highly profitable and sustainable. As a result, we believe we are extremely well positioned heading into to 2021, as we kick off our U.S. expansion strategy. In this regard, we anticipate a number of very meaningful near-term milestones and look forward to providing updates on our roll-out as developments unfold."
     
    #2145     Mar 2, 2021
  6. Apple and Waymo Veteran Executive, Tim Willis, Joins Aeva as Vice President of Global Supply, Manufacturing and Strategy

    still called IPV
     
    #2146     Mar 2, 2021
  7. I got to say I'm liking the look of this DAO.

    ST target $38.

    Now $34.40

    Buypoint would be $33.80 not far

    Mid term taget $41 and up....
     
    #2147     Mar 2, 2021
  8. Adding to the DAO story is this.

    Youdao 7M share Secondary priced at $34.00 »

    This was 2/11 so that conceivably could be support! -$34.00.
     
    #2148     Mar 2, 2021
  9. <<TOP 5 Watch>>

    1- DAO

    2- ELYS

    3- VWAGY

    4- ABB

    5-LYB
     
    #2149     Mar 2, 2021
  10. Wise Words?
    2/10

    Gamida Cell price target raised to $27 from $15 at H.C. Wainwright 02/10 GMDA H.C. Wainwright analyst Vernon Bernardino raised the firm's price target on Gamida Cell to $27 from $15 and reiterates a Buy rating on the shares after the company made an oral presentation of full efficacy and safety results from the Phase 3 clinical trial with its lead product candidate, omidubicel. The analyst is positive on the full results and believes omidubicel "could be transformative" in a real world setting in bone marrow transplant procedures. He made Gamida Cell stock a "Top Pick for 2021."

    Now we have this secondary then.... Blast Off! Could this stock really go from $9 to $27?
    Cathy Wood Of Ark may think so!
     
    #2150     Mar 2, 2021